In addition, increased expression of this lncRNA in gastric cancer patients can predict poor prognosis and promotes tumorigenesis by epigenetically silencing EphB3 (EPH receptor B3) via EZH2 and LSD1, also known as KDM1A (lysine demethylase 1A) [110]. The gene discussed is EPHB3; the disease is gastric cancer.